With just one subscription to Beyond the Wall Investing , you can save thousands of dollars a year on equity research reports from banks. You'll keep your finger on the pulse and have access to the latest and highest-quality analysis of this type of information.I first wrote about Cytek Biosciences, Inc. (NASDAQ: CTKB ) stock before it even went public ( July 21, 2021 ) with a "Buy" rating with a thesis that it was alreadyHe leads the investing group Beyond the Wall Investing with features that include: a f ...